Skip to content
Menu

B of A Securities Downgrades National Health Investors to Underperform, Lowers Price Target to $67

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsDowngradesPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

B of A Securities analyst Joshua Dennerlein downgrades National Health Investors (NYSE:NHI) from Buy to Underperform and lowers the price target from $86 to $67.

B of A Securities analyst Joshua Dennerlein downgrades National Health Investors (NYSE:NHI) from Buy to Underperform and lowers the price target from $86 to $67.

Read at benzinga.com